Public annual accounts

DR.L.SCHREVENS,pneumologie financials

Name: DR.L.SCHREVENS,pneumologie financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR.L.SCHREVENS,pneumologie, with comparable measures and links to available source documents.

Company overview

Registry number

0888857322

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DR.L.SCHREVENS,pneumologie

2025 versus 2024

Operating line: €323,708
EBITDA: €319,028
Total assets: €1,176,447
Equity: €1,140,177

EBITDA margin +98.6% · Equity ratio +96.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€323,708	€319,028	€1,176,447	€1,140,177	-
202431 Dec 2024	€312,540	€307,932	€1,212,637	€1,091,296	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€323,708

€319,028

€1,176,447

€1,140,177

202431 Dec 2024

€312,540

€307,932

€1,212,637

€1,091,296